Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
Manager
Telephone: 412-623-4701 or 412-586-9773
Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.

Magee-Womens Hospital of UPMC Launches Clinical Trial for Patients with Recurrent Ovarian Cancer

PITTSBURGH, April 7, 2010 – Magee-Womens Hospital of UPMC will be the only site in Western Pennsylvania for a clinical trial of ABT-888, a drug previously proven in combination treatments to improve chemotherapy’s effectiveness by lowering cancer cells’ resistance to treatment.

ABT-888 works by targeting the polymerase (PARP) family of enzymes responsible for a wide variety of processes in cancer cells, according to Kristin Zorn, M.D., the principal investigator for the trial at Magee and a gynecologic oncologist with the Magee-Womens Gynecologic Cancer Program of UPMC Cancer Centers. PARP inhibition currently is being studied as a mechanism that may be particularly effective for treating cancers related to BRCA 1 and BRCA 2 mutations, which can be inherited in families with strong histories of breast, ovarian, fallopian tube and peritoneal cancers.

“Cancer cells have increased levels of PARP, which we believe causes resistance to chemotherapies and other cancer treatments,” said Dr. Zorn. “ABT-888 appears to inhibit PARP, making cancer cells more sensitive to chemotherapy and to cell death.”

Ovarian cancer is the second most common and most lethal of gynecologic cancers, and the fifth most frequent cause of cancer death in women. About 21,550 women were diagnosed last year with the disease, and 15,000 died from it. Ovarian cancer has few symptoms in its early stages, and, because of this, patients often are diagnosed after the disease has started to spread.

The study is open to patients with recurrent ovarian, fallopian tube or peritoneal cancers who have received previous chemotherapy treatments. Patients who enroll in this clinical trial will either receive ABT-888 in conjunction with chemotherapy or chemotherapy alone. If at any time a patient’s disease progresses on the chemotherapy alone arm, she can then move to the ABT-888 arm of the study. For more information, contact Vicki Gilchrist, R.N., at (412) 641-4365.

The study is sponsored by Abbott Laboratories.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com